1. Zhang, Yunxiao, Wen, Yunyu, Nie, Jing, Qi, Songtao, Xie, Sidi. 2023. MYEF2: an immune infiltration-related prognostic factor in IDH-wild-type glioblastoma. In Aging, 15, 7760-7780. doi:10.18632/aging.204939. https://pubmed.ncbi.nlm.nih.gov/37556355/
2. Zhang, Peng, Zhao, Jiang-Hua, Chen, Lin, Wang, Hui-Xuan, Cai, Wei-Hua. 2023. Expression and function of myelin expression factor 2 in hepatocellular carcinoma. In BMC gastroenterology, 23, 20. doi:10.1186/s12876-023-02644-3. https://pubmed.ncbi.nlm.nih.gov/36658471/
3. Kim, Hyeon Woo, Baek, Minjae, Jung, Sanghyun, Kwak, Beom Seok, Kim, Sun Jung. 2023. ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer. In Epigenetics, 18, 2276384. doi:10.1080/15592294.2023.2276384. https://pubmed.ncbi.nlm.nih.gov/37908128/
4. Wang, Runqing, Xu, Jin, Tang, Yuning, Peng, Yu, Zhang, Zheng. 2023. Transcriptome-wide analysis reveals the coregulation of RNA-binding proteins and alternative splicing genes in the development of atherosclerosis. In Scientific reports, 13, 1764. doi:10.1038/s41598-022-26556-6. https://pubmed.ncbi.nlm.nih.gov/36720950/
5. Li, Zhi-Xiao, Li, Yu-Juan, Wang, Qian, Feng, Mao-Hui, Xiang, Hong-Bing. 2021. Characterization of novel lncRNAs in upper thoracic spinal cords of rats with myocardial ischemia-reperfusion injuries. In Experimental and therapeutic medicine, 21, 352. doi:10.3892/etm.2021.9783. https://pubmed.ncbi.nlm.nih.gov/33732325/
智鼠故事 
